Therapeutic drug monitoring for vancomycin: past, present and future
Nicole M. Ondrush, PharmD, AAHIVP ; Bryan T. Mogle, PharmD, BCPS Vancomycin remains a mainstay of treatment for invasive infections caused by methicillin-resistant Staphylococcus aureus, and requires therapeutic drug monitoring (TDM) for optimal drug delivery. Herein, we discuss various methods of performing TDM for vancomycin, challenges associated with each method, and future directions for vancomycin […]
